A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Sponsor
University of Chicago (Other)
Overall Status
Recruiting
CT.gov ID
NCT00470327
Collaborator
Idiopathic Pulmonary Fibrosis Clinical Research Network (Other)
4,000
1
243
16.5
Study Details
Study Description
Brief Summary
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
4000 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Actual Study Start Date
:
Sep 1, 2005
Anticipated Primary Completion Date
:
Dec 1, 2020
Anticipated Study Completion Date
:
Dec 1, 2025
Outcome Measures
Primary Outcome Measures
- Natural history of course of disease in patients with Interstitial lung disease (ILD) [Yearly]
We assess mortality roughly yearly but duration is unlimited
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Interstitial lung disease
Exclusion Criteria:
- Does not have Interstitial lung disease
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Chicago | Chicago | Illinois | United States | 60637 |
Sponsors and Collaborators
- University of Chicago
- Idiopathic Pulmonary Fibrosis Clinical Research Network
Investigators
- Principal Investigator: Mary E Strek, MD, University of Chicago
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University of Chicago
ClinicalTrials.gov Identifier:
NCT00470327
Other Study ID Numbers:
- 14163A
First Posted:
May 7, 2007
Last Update Posted:
Aug 8, 2019
Last Verified:
Aug 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Chicago
Additional relevant MeSH terms: